Literature DB >> 21453763

Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.

Ilva D Rupenthal1, Colin R Green, Raid G Alany.   

Abstract

In situ gelling systems are viscous polymer-based solutions that exhibit a sol-to-gel phase transition upon change in a physicochemical parameter such as ionic strength, temperature or pH, therefore prolonging the formulations' residence time on the ocular surface. Ion-activated in situ gelling systems, that are able to crosslink with the cations in the tear fluid, have previously been evaluated in terms of their rheological, textural and in vitro release characteristics. The present study describes the ocular irritancy, precorneal retention time and in vivo release characteristics of the same formulations. It was shown that all tested polymer systems were non-irritant. Precorneal retention studies revealed a biphasic rapid release for the solution with less than 40% radioactivity left on the ocular surface after 15 min, while formulations based on gellan gum, xanthan gum and carrageenan seemed to drain at an almost constant rate with more than 80% radioactivity remaining. This was in agreement with the in vivo miotic studies, which demonstrated that the area under the curve and the miotic response at 120 min after administration for gellan gum, xanthan gum and carrageenan formulations of pilocarpine were increased by 2.5-fold compared to an aqueous solution, which demonstrates their potential use in ophthalmic formulations.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21453763     DOI: 10.1016/j.ijpharm.2011.03.043

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

Review 1.  Novel Eye Drop Delivery Systems: Advance on Formulation Design Strategies Targeting Anterior and Posterior Segments of the Eye.

Authors:  Yaru Wang; Changhong Wang
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

2.  Ocular films versus film-forming liquid systems for enhanced ocular drug delivery.

Authors:  Hamdia G Wafa; Ebtessam A Essa; Alaa E El-Sisi; Gamal M El Maghraby
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

3.  Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids.

Authors:  Rohit Bisht; Ilva D Rupenthal; Sreevalsan Sreebhavan; Jagdish K Jaiswal
Journal:  J Pharm Anal       Date:  2017-06-23

4.  In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics.

Authors:  Pierre-Louis Destruel; Ni Zeng; Françoise Brignole-Baudouin; Sophie Douat; Johanne Seguin; Elodie Olivier; Melody Dutot; Patrice Rat; Sophie Dufaÿ; Amélie Dufaÿ-Wojcicki; Marc Maury; Nathalie Mignet; Vincent Boudy
Journal:  Pharmaceutics       Date:  2020-04-15       Impact factor: 6.321

Review 5.  Research progress of in-situ gelling ophthalmic drug delivery system.

Authors:  Yumei Wu; Yuanyuan Liu; Xinyue Li; Dereje Kebebe; Bing Zhang; Jing Ren; Jun Lu; Jiawei Li; Shouying Du; Zhidong Liu
Journal:  Asian J Pharm Sci       Date:  2018-05-24       Impact factor: 6.598

6.  The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats.

Authors:  Inge J M Slenter; Sylvia C Djajadiningrat-Laanen; Daphne J Elders; Reinoud de Gee; Linda E Koele; Loes W Vermeer; Michael H Boevé
Journal:  Vet Ophthalmol       Date:  2019-05-17       Impact factor: 1.644

Review 7.  More than Antibiotics: Latest Therapeutics in the Treatment and Prevention of Ocular Surface Infections.

Authors:  Ming-Cheng Chiang; Edward Chern
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

8.  Studies on Surfactants, Cosurfactants, and Oils for Prospective Use in Formulation of Ketorolac Tromethamine Ophthalmic Nanoemulsions.

Authors:  Shahla S Smail; Mowafaq M Ghareeb; Huner K Omer; Ali A Al-Kinani; Raid G Alany
Journal:  Pharmaceutics       Date:  2021-03-30       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.